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Objectives . The purpose of this study was to test the feasibility
of implanting and retrieving a heat-activated recoverable tempo-
rary stmt and to determine its effect on the angiographie, gross
and histologic appearance of a normal coronary artery wall.
Background, Permanent coronary stealing Is associated with a
significant incidence of thrombosis, bleeding and vascular compll-
cations. These may lie avoided by temporarily slenting for a
period of hours to several days.
Methods. Seventy-eight stents constructed from the shape-
memory nickel-titanium alloy nitinol were deployed by balloon
expansion I sp the coronary arteries of 28 dogs and left in place for
up to 6 months . Thirty minutes to I week after implantation, 70
steats were recovered by Rushing the coronary arteries with 3 to
S ml of 75°C lactated Ringer solution, with collapse of the stent
over a recovery catheter and subsequent withdrawal .
Metallic stents have been deployed in human coronary
arteries both for primary treatment of stenosis and for
lumen-compromising intimal dissection after angioplasty
(1-5). The primary mechanism of action of these devices is
prevention of elastic recoil and "tacking down" of flaps and
dissections . Although deployment generally establishes a
widely patent vessel, a major drawback has been subacute
thrombosis, necessitating prolonged anticoagulation therapy
with increased risk of bleeding, especially in the presence of
dissection or thrombus (6-8) . A temporary stent that is
removable hours to days after implantation might provide
some of the benefits of permanently implantable stems and
potentially mitigate some of their limitations .
The purpose of this study was to test the feasibility of
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Results . All stents were successfully recovered and removed
percutaneously . Mean vessel diameter after stenting was 12 :t 6%
(p < 0.05) greater than baseline diameter . Mean vessel diameter
after stmt removal remained enlarged (6 t 3%, p < 0 .05). No
anglographic or gross evidence of thrombosis, dissection, emboli-
xation, migration or spasm was associated with implantation or
recovery . Microscopic examination
revealed minor intimal injury
In 40 segments (51%). Microscopic focal medial necrosis was
associated with mural platelet-fibrin thrombus In 23 scented
segments (29%) and media was interrupted in 7
(9%) .
Conclussions . This study demonstrates the feasibility of a new
method of temporary stenting that uses the thermoelastic proper-
ties of nitinol to permit reliable recovery of the stent in normal
canine coronary arteries.
(J Am Call Cardiol 1993;22:1207-13)
implanting and retrieving a heat-activated recoverable tem-
porary stem (HARTS device) and to determine the effect of
temporary stenting on the angiographic . gross and histologic
appearance of a normal coronary artery wall .
Methods
Heat-activated recoverable temporary stmt device . The
prototype device (Advanced Coronary Technologies) was
constructed from multiple segments of nickel-titanium alloy
(nitinol) wire 0.009 in. (0.023 cm) in diameter. The wire
segments were connected by stainless steel tubing crimp
joints to form a tubular, meshed stent (Fig . I a) . Undeployed,
the scent is l5 mm in length with an outer diameter of
1.5 mm. but it can be balloon expanded to a diameter of
4.0 mm. The stent shortens in length as it is expanded, so
that at 4 .0 mm in diameter it is 13
.8 mm in length . Distances
between the midpoint of adjacent afid opposing struts are
0.66 and 1 .45 mm, respectively, for the unexpanded stent
.
Nitinol exists in either the martensite or austenite crystal
phase. At body temperature, the stent alloy contains a higher
martensitic fraction, which gives it a deformable structure .
The HARTS device is inserted in the collapsed configura-
tion, mounted on a delivery balloon, and is deployed
by
balloon expansion (Fig . lb). Such deformation further in-
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Ftgure 1. Prototype heat-activated removable temporary scent
(HARTS) device : A, Unexpanded scent . B, Expanded stent on a
delivery balloon . C, Collapsed scent on recovery catheter .
creases the martensitic fraction of some variants as well as
the axial flexibility of the device .
Austenitic phase transition occurs when the metal is
heated above a specific temperature, which can be chosen
according to the composition of the alloy . The transition
temperature of the prototype stent was 55C . On heating, the
expanded scent undergoes a thermoelastic phase transition,
resulting in collapse of the stent to its original unexpended
configuration (Fig. !c). This phase change occurs at the
speed of sound and with considerable force. The stent grips
the recovery catheter tightly, providing a mechanism for
recovery anal remrwal of the deployed scent from the coro-
nary arteries .
Aiheab. Animal experiments were performed according
to the "Guide for the Care and Use of Laboratory Animals"
WHEW publication No. NIH-80.23), and the protocol was
approved by the Institutional Animal Care and Use Commit-
tee of Cedars-Sinai Medical Center. Twenty-eight mongrel
dogs weighing 25 to 30 kg were pretreated with aspirin
(325 mg) and dipyridamole (75 mg) I day before the proce-
dure. Anesthesia was induc :d with intravenous sodium
thiopental (30 mglkg body weight), and the trachea was
intubated. The dogs were ventilated with I to 1 .5 minimal
alveolar concentration of isollurano and oxygen. Procedures
were performed with continuous electrocardiographic and
blood pressure monitoring. An 8F side-arm introducer
sheath was placed in the left carotid artery after surgical
cutdtram . Activated clotting time was measured, and 5,000 U
of intravenous heparin was administered
. Activated clotting
time was maintained at >300 s until the scent was implanted .
After stmt implantation, the dogs received a daily dose of
Table 1 . Location and Duration of Stent Implantation
LAD
m
left anterior descending coronary artery ; LCx = left circumflex
coronary entry.
10,000 U of subcutaneous heparin for up to 10 days . Low
molecular weight dextran (Rheomacrodex, Pharmacia Inc .)
was administered at a rate of 50 mllh for the duration of the
procedure .
An 8F percutaneous transluminal coronary angioplasty
guiding catheter (Schneider) with a JR5 or hockey-stick
curve was positioned selectively into the left coronary
artery . Coronary arteriography was performed in the left
lateral projection by hand injection of 4 to 5 ml of contrast
medium (Angiovist, Berlex Labs), and X-ray exposures
were made with a Siemens (Erlangen) Gigantos cineangiog-
raphy system using the 6-in. (15-cm) image intensifier. Im-
ages were recorded at a dose of 0 .3 pGy/frame on 35-mm
cinc film at 30 framesls and on U-matic 0.75-in. (1.9-cm)
videotape .
Stunt Implantation. The location and duration of stent
deployment are summarized in Table 1 . A custom-made
3.0- to 4.0-mm diameter over the wire balloon catheter
(Advanced Coronary Technologies) 20% to 50% larger in
diameter than the target vessel was chosen . The device was
crimped over the collapsed balloon to comprise the stent
delivery system . This was advanced into the selected coro-
nary artery segment using standard angioplasty techniques
and a 0.014-in. (0.036 cm) guide wire (Advanced Cardiovas-
cular Systems, Inc .) . Two dilation of 6 to 8 atm for 15 s
were performed to expand the stent . Expanded balloon
diameters of 3.0 or 3.5 mm were required for left anterior
descending coronary artery implantation and 3 .5 or 4 .0 mm
for left circumflex coronary artery implantation . The de-
flated balloon and guide wire were then removed, leaving the
expanded stem embedded in the vessel wall (Fig . 2, A and
B). Patency was confirmed by repeat angiography .
A total of 78 devices were placed in the mid to distal
regions of the left circumflex, left anterior descending and
diagonal branches of the left anterior descending coronary
artery in 23 dogs .* A different segment of the same vessel
*One additional experiment was performed ; however, the animal did not
receive pretreatment with aspirin and dipyridamole . Because this was not
according to protocol, the results are not included in the summarized data
One of the two stems implanted thrombosed after 30 min. Gross and
microscopic inspection revealed a white, platelet-rich thrombus .
No of
Dogs
(n = 28)
Stents Implanted Duration (h)
LAD
(n = 37)
LCx
(n = 41) 0.5
1 .5-5 24 72
2 4 3
7
10
17 22 23 16
4 4 4 8
4 4 4 -
8
4
4 4 1 wk
2
2 2 6wk
2 2 2 6mo
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Figure 2. Left coronary arteriogram before and after stent delivery :
A, Left coronary artery angiogram. B, Fluoroscopic appearance of
delivered stent devices in the left anterior descending and left circum-
flex coronary arteries. C, Recovery catheter coaxially positioned
through expanded scent in the left anterior descending coronary
artery . D, Thermal collapse of stent on the recovery catheter . E, Left
coronary artery arteriogram after recovery of both devices .
EIGLER ET AL .
	
1209
TEMPORARY METALLIC STENTS IN CANINE CORONARY ARTERIES
1210
	
EIGLER ET AL
.
TEMPORARY METALLIC STENTS IN CANINE CORONARY ARTERIES
was chosen on 31 occasions to place a second stent after
removal of the first (Table 1). There were 37 left anterior
descending and 41 left circumflex coronary artery stem
placements .
Stint recovery. Stent recovery was attempted 30 min to 6
weeks after deployment (Table 1) . After angiographic con-
firmation of vessel patency, a J-tip 0.014-in. guide wire was
placed through the stent and advanced into the distal seg-
ment of the artery. Multiple views were obtained, and
particular attention was given to free mobility of the wire
through the steal to ensure that the wire was coaxial within
the stent. A recovery catheter (Advanced Coronary Tech-
nologies) was advanced coaxially through the implanted
stem until two platinum markers that delineate a 20-mm
steal recovery zone straddled the stent (Fig. 2C)
. To col-
lapse the stent, 3 to 5 ml of lactated Ringer solution pre •
heated to 75° to 80°C was hand injected as rapidly as possible
into the proximal Y-adapter of the recovery catheter and
exited through multiple side holes just proximal to the scent
(Fig. 2D). In bench simulation this tE :;.hnique delivers a pulse
of 60° to 65°C liquid at the distal delivery site .
The scent-catheter recovery system was then with-
drawn from the coronary artery and either removed by
exiting through the guide catheter or by pullback through
the introducer sheath . Elapsed time from the guide cath-
eter insertion to retrieval of the device did not exceed
5 min. Repeat angiography was performed, followed by
euthanasia with intravenous potassium chloride while the
animal was under general anesthesia . The coronary arteries
were perfused in situ with formalin for 15 min . The heart
was excised and fixed in formalin. Angiographic interpre-
tation was by consensus of two observers (N.L.E. and
M,J.K .). Relative vessel diameter was measured with hand-
held calipers .
Grass and microscopic ex ation. All recovered stents
underwent gross inspection after removal for evidence of
vascular tissue or thrombus under a dissecting microscope at
x25. The 16 stents implanted for >24 h were fixed in 2 .5%
glutarakiehyde, and scanning electron microscopy (Hitachi
S405) of these stents was performed.
After fixation, all arterial segments were visually in-
spected for extravascular hemorrhage . Serial 2-mm seg-
ments of vessels were cut from the site of stent implantation
and from areas distal and proximal to the stent . After routine
processing, sections were cut and stained with hematoxylin-
eosin for light microscopic evaluation by an experienced
cardiac pathologist (M.C.F .) . Pathologic findings were cate-
gorized according to the degree of vascular
injury into three
prospectively defined classes, class I, minimal intimal injury
consisting of focal endothelial damage and disturbance of the
internal elastic lamina in the stented segments ; class II,
intimal injury associated with platelet-fibrin thrombi and
focal medial necrosis evident by absence of smooth muscle
cell nuclei, and class iii, medial disruption .
An lysis. Vessel diameter after implantation and recov-
ery was compared with the diameter of adjacent unstented
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Figure 3. Vessel diameter after implantation and recovery . Y-axis
values are normalized for baseline (adjacent unscented segment
m
1). Mean vessel diameter after implantation was 12 t 6% larger than
that of the adjacent segment. Mean vessel diameter after recovery
was 6 t 3% larger than that of the adjacent segment .
segments and shown as mean value ± SD. Statistical anal-
ysis was performed using the paired t test.
Results
Implantation of stems. The stents were easily visible
under fluoroscopy . All scents were successfully delivered to
the target vessels without embolization, migration, dissec-
tion, spasm or rupture recognizable on the postdelivery
angiogram. All stented vessels remained patent without
angiographic evidence of thrombus or side branch occlusion .
The stented segments of the vessels were 12 ± 6% (p < 0.05)
larger in diameter than the adjacent unstented segments (Fig .
3) .
Recovery of stems. The transcatheter/sheath recovery
procedure was successful in all 70 scents implanted up to I
week. A single injection of 3 to 5 ml of heated lactated Ringer
solution was successful in all cases in collapsing the stent.
By fluoroscopy each stout was observed to collapse onto the
recovery catheter between the angiographic markers without
embolization . Stented arterial segments maintained a diam-
eter equal to or greater than that of adjacent proximal
segments after removal of the stem (Fig. 2e). The mean
diameter of these segments was 6 ± 3% (p < 0 .05) larger
than that of the adjacent unstented segment by caliper
measurements (Fig . 3). No arrhythmias or hemodynamic
changes were associated with intracoronary injection of the
thermal bolus. Segments measured after 6 weeks and 6
months of stent implantation had 22 ± 5% and 36 ± 8%
diameter stenosis, respectively. The stems implanted for six
weeks were not recoverable with a thermal bolus .
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Figure 4 . Histologic changes after scenting. a, Class I injury : stented
segment of the left anterior descending coronary artery in Dog 12
after removal of the device, which had been implanted for 24 h . Mild
intimal injury is present . Note fragmentation of internal elastic
lamina (arrowheads) . The media and adventitia are intact . b, Class II
injury : section of a stented segment of the left circumflex coronary
artery in Dog 13 . The device was removed 24 h after implantation .
A platelet-fibrin thrombus is seen attached to the vessel wall at a
small branch site (asterisk). Nuclei are sparse in the media to right of
the thrombus. c, Class III injury: section of a segment of the left
anterior descending coronary artery in Dog 2, where perivascular
hemorrhage was seen on gross inspection . The device was removed
30 min after implantation . Note site of medial disruption of the
vessel wall (arrows) with hemorrhage into the adventitia adjacent to
the rupture (r) site . Hemaloxylin-eosin stains x50 (a and b), x25 (c) .
Gross and microscopic histopatllologlc findings . No vas-
cular tissue was noted on gross examination of the stems
after removal. Under dissecting microscope the scents ap-
peared to be free of thrombus or vascular tissue . A thin red
layer was noted covering approximately 50'0 of the surface
area of the stents .
Gross examination of the hearts revealed limited periad-
ventitial hemorrhage at the site of stent deployment in 7 of 78
stented segments. This appeared as myocardial staining in
the area immediately next to the arterial segment . In all such
cases the ratio of expanded balloon size to vessel diameter
exceeded 1.4 :1 .
Examples of the three injury classes are shown in Figure
4. There was evidence of class I injury in 40 (51%) stented
segments . In addition, there were microscopic platelet fibrin
thrombi in 23 (29%) stented segments representing class II
injury. The seven (9%) arterial segments with gross periad-
ventitial hemorrhage showed medial disruption on micro-
scopic examination and thus were categorized as class III
injury. The severity of injury did not correlate with the
duration of implantation . In six cases of medial disruption,
the stents were implanted for <5 h . Minimal endothelial
injury was observed proximal to the site of the implantation .
Vascular histologic findings were normal distal to the site of
the implantation . There was no evidence of distal emboliza-
tion on serial cuts through the myocardium . The stents that
were left in place for 6 weeks and 6 months were overgrown
with neointimal proliferation (Fig . 5, a and b). Scanning
electron microscopy revealed a thin, amorphous layer cov-
ering the stents and occasional red blood cells . There were
few platelets and fibrin strands (9) .
Discussion
Deployment and recovery. This report is the first descrip-
tion of a heat-activated removable temporary stent. Seventy-
eight stents were successfully deployed by balloon expan-
sion. The stent had sufficient structural strength to maintain
an arterial lumen diameter lar er than baseline diameter for
the duration of implantation . All 70 stents implanted for up
to I week were successfully recovered on a coaxially placed
EIGLER ET AL
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catheter. Stents implanted for 6 weeks were net recoverable
because of entrapment by neointimal proliferative tissue .
The ease of stent recovery was the most notable charac-
teristic of the device. This was accomplished by briefly
flushing the coronary artery with small quantities of crystal-
loid solution to achieve heating of the
stent above its
transition temperature of 55°C . The vessel and the device
cool quickly to body temperature because coronary blood
flow disperses the thermal bolus and results in collapse of the
scent to its original dimensions .
The dynamic recovery
1212
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Figure S. a, Histologic sections of the left anterior descending
coronary artery 6 months after stent implantations . Asterisks repre-
sent the voids where the stem struts have been removed . A layer of
neointima surrounds the struts . b, Enlargement of the area sur-
rounding a stem strut void showing fibrin deposition (arrow) and
inflammatory cell infiltration present . Hematoxylin-eosin stains x 10
(a), x50 (b) . reduced by 5%.
process (stent collapse) was always well visualized by fluo-
roscopy . The recovery catheter, with the stent device firmly
adherent to it, was successfully withdrawn through the guide
catheter or the introducer sheath. There were no instances of
device embolization during deployment or recovery . All
vessels remained angiographically patent, without evidence
of thrombosis or dissection.
Hlstalo2c fiodhp. Placement and removal of the stent
were associated with some evidence of vascular injury at the
implantation site in all cases . This was generally limited to
focal intimal or medial injury that was localized to the
position of stent struts, with preserved intima in the in er-
vet segments. With extreme dilation (` 1,4 to I normal
diameter), there was disruption of the intima and media, with
periadventitial hemorrhage
. There was no relation between
the extent of vascular injury and the duration of stem
placement
. Endothelial injury insufficient to cause sloughing
proximal or distal to the stem or between regions of strut/
vessel contact could have occurred that would not be
appreciated on light microscopy . Pathologic findings of
permanent stenting and of balloon angioplasty of normal
arteries have been well defined (9). The present findings are
consistent with a similar degree of vascular injury .
There was no angiographic or gross pathologic evidence
of thrombus formation . Histologic study revealed micro-
scopic mural thrombi in one third of the stented sites, and
scanning electron microscopic examination of the recovered
stents revealed occasional fibrin, red blood cells and plate-
lets. The one experiment in which the dog did not receive
aspirin and dipyridamole suggests the importance of anti-
platelet therapy . Although the dog was sufficiently anticoag-
ulated with heparin, a stent thrombosed shortly after implan-
tation .
Prospects for temporary slanting. Removable metallic
stents and permanent nitinol stents have been previously
described. A mechanically activated relocatable stent was
tested in the inferior vena cava of dogs. but this device is
probably too large and too difficult to use in the coronary
circulation (10) . The very first permanent vascular stent,
described by Dotter et al . (11), was made of nitinol (11). The
present device differs significantly from the stent of Dotter et
al. and its subsequent iterations, which use the thermoelastic
phase change of nitinol as a mechanism to deploy a perma-
nent stent (12) . To our knowledge, this report represents the
first successful attempt to exploit the austenitic phase tran-
sition of nitinol to achieve stent collapse, thus creating a
removable temporary coronary stem .
The clinical value of a removable stent has yet to be
demonstrated . All metallic coronary stents are capable of
restoring flow after acute intimal dissection or suboptimal
balloon dilation. There is preliminary evidence that stents
may lower the rate of restenosis when implanted in large,
previously undilated coronary vessels or vein grafts (13) .
However, permanent stents are associated with a signifi-
cantly increased incidence of subacute thrombosis (3% to
27%) that occurs from several days to 4 weeks after implan-
tation (1,2) . When stents are implanted as a bailout device
after acute closure, the incidence of subacute thrombosis
increases to between 16% and 27% (8). Consequently, ex-
tensive antiplatelet and anticoagulant therapy is required,
which in turn necessitates an expensive, prolonged hospital
stay. The antithrombotic measures are associated with a 7%
to 10% incidence of major bleeding or vascular complica-
tions requiring transfusions or surgery, or both (1,14) . A
temporary stent may have a role in treatment of flow-
compromising intimal dissection because prolonged balloon
inflation for between 20 min and 15 h has been reported to
stabilize lumen-compromising dissections (15-17) . Poten-
tially, intimal "tacking" for several hours to a few days
could stabilize the dissection yet still allow the stent to be
removed before the time of peak incidence of subacute
thrombosis (days 4 to 10). Conceivably, anticoagulation
would not be required after device removal, thereby poten-
tially reducing hospital costs and complications related to
prolonged anticoagulant therapy. Further study will be
JACC Vol
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needed to determine whether removing the scent days to
hours after implantation confers any of these advantages .
A second application for stenting is to enlarge lumen
diameter when balloon angioplasty results are suboptimal
(4,8) . It is possible that temporary stenting for hours to days
could achieve a similar effect . Permanently implanted stents
may reduce restenosis by eiiminating elastic recoil ; how-
ever, Schwartz et al . (18) have shown that such stents can
also be a potent stimulus for smooth muscle cell proliferation
and restenosis . It therefore appears that reduction in resten-
osis involves a trade-off between maximal lumen expansion
and exaggerated intimal hyperplasia . It is conceivable that
temporary stenting could inhibit elastic recoil, maintaining
lumen expansion without inducing the degree of intimal prolif-
eration associated with a permanent implant . As with the other
hypothetic advantages of temporary stenting, these specula-
tions will require extensive preclinical and clinical study .
Study limitations . Our study is preliminary and subject to
several significant limitations . 1) The normal canine coro-
nary artery is not necessarily comparable to the diseased
human coronary artery . It may be more forgiving of mechan-
ical intervention. Conversely, it is probably more prone to
medial rupture under the study circumstances because the
stents had to be expanded to a size greater than the vessel to
ensure implantation in these normal vessels . 2) Our study did
not examine the capability of this device to "tack" intimal
dissections or to produce sustained vascular dilation after
removal. On bench testing, the expanded device endures
greater radial compressive force than is endured by currently
available balloon-expandable stents . The device reported
here is a handmade prototype that, when fully expanded,
leaves substantial vascular surface unsupported. A refined
version of the de' . .c : is now being fabricated from nitinol
tubing, which will have a transition temperature of 45° to
48°C and a geometric configuration similar to the slotted tube
design of the Palmaz-Schatz stent. This new device may thus
share many mechanical properties of the Palmaz-Schatz
stent, with the added advantage of being removable . These
issues will require careful evaluation in subsequent studies .
Summary. We have demonstrated the feasibility of a new
method for temporary stenting of the coronary arteries that
uses the special thermoelastic properties of nitinol to permit
satisfactory deployment, balloon expansion and recovery of
the device in normal canine coronary arteries. Extensive
EIGLER ET AL .
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further research will be required to determine whether
temporary stem placement has useful clinical applications
.
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